Sales Force Effectiveness USA 2010

eyeforpharma17-18 May 2010, Princeton, NJ, USA.
SFE USA is a premier conference for pharma. Learn how to develop a winning sales strategy from pharma leaders. 10 Industry VPs will deliver sessions on healthcare reform, customer-centric models, and CRM tools.

SFE USA Program

Pharma In 2010 And Beyond

  • Lean, Mean, Switching machines- What is the future of Sales Force Effectiveness?
    Tony Fross, Senior Director WBB Business Excellence Group, Pfizer
  • Mergers & Acquisitions: What does the future hold?
    Richard Skelly, Senior Director Commercial Evaluations, AstraZeneca
  • Emerging Markets: Building BRIC(s) and Blocs
    Charlotte Sibley, Senior Vice President CBS Business Management, Shire
  • The future of pharma rests on the impending Health Care bill – be prepared and understand the implications
    Pharma Vice President confirmed, Genentech

Sales Excellence

  • Achieve more with less: Which commercial model will be most successful for your company?
    Barry Duke, Vice President Sales, Genzyme
  • Insights into Taro's commercial model strategies
    Joe Malta, Vice President Sales & Marketing, Taro Pharmaceuticals
  • The optimal size of your workforce: How small is big enough?
    Tracy Mills, Senior Director Sales Force Effectiveness, Endo Pharmaceuticals
  • Target managed markets and bring value to these powerful stakeholders
    Don Sawyer, Vice President Commercial Operations, AstraZeneca
  • How to ensure a long-term relationship with your key accounts
    Tony Zecca, Senior Director Sales Strategy, Effectiveness & Innovation, AstraZeneca

Sales Tools And Technology

  • Multi-Channel Management: Integrating promotion effectively across all channels
    Paulash Mohsen, VP Multichannel Marketing, Pfizer
  • Capitalise on the potential of e-detailing to reduce your marketing costs
    John Rotondo, VP & General Manager Commercial Operations, Bayer
  • Case Study: Closed Loop Marketing In A multi-channel environment
    Marc Valdiviezo, Director Marketing Excellence, Sanofi-Aventis
  • What technology should you provide your sales force to achieve optimum sales effectiveness?
    Edson Gemo, Senior Director Business Technology Sales Force Effectiveness Solution Center, Pfizer
    Steve Winawer, Senior Director, US Business Technology, Commercial Operations, Patient & Physician Marketing, Pfizer

Training And Development

  • The Evolution of Physician Behaviour and Implications for New Physician Access Models
    Mark Gleason, Senior Vice President, Corporate Development, Aptilon
  • SUPER PANEL: Scientist Vs salesman: Which approach will enable your sales reps to raise their value to the industry?
    Tim Ryan, Executive Director, Boehringer Ingelheim
    Christine Barczak, East Area Vice Presidnet, GSK
    Todd Lambert, Vice President Sales, Shire,
    Don Hribek, Senior Director of Strategic Accounts, EMD Serono
    Moderator: Greg Neal, Managing Partner, Rx Business Advantage Consulting
  • A sales force to be reckoned with: Transforming Sales Forces with talent upgrades, skills training, and business processes
    Joe Coffey, Vice President Sales, Baxter
  • Case Study: Discover the methodology behind successful training delivery
    Mike Capaldi, AVP Sales Training & Leadership Development, Sanofi-Aventis
  • Value Creation- The Next Frontier for Pharma
    Angela Bakker Lee, Principal, ZS Associates

For further information and registration, please visit:

Most Popular Now

Novo Nordisk announces plans to transform its appr…

Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious c...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Sat...

World's largest Alzheimer's survey reveals most ad…

Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest glob...

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Pre-clinical success for a universal flu vaccine o…

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Co...

Discovery could explain failed clinical trials for…

Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trial...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

Aspirin found not to prolong healthy aging

Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial p...

The Lancet Respiratory Medicine publishes first Ph…

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

Clinical gene discovery program solves 30 medical …

A table in a recently published paper tells the story of 30 families who have, sometimes after years of searching, finally received an answer about the condition that has...